Mentor
This article was originally published in The Gray Sheet
Executive Summary
Saline-filled testicular prosthesis will be the only testicular implant available upon its launch later this summer, the firm says. PMA approval was announced July 24. Separately, Mentor reported first quarter (ended June 30) net income of $16.7 mil. ($0.68 per share), an increase of 62% over last year...